Breaking News

Swedish Orphan Biovitrum AB ADR (SWTUY)

OTC Markets

Add to/Remove from a Portfolio Add to Watchlist

Swedish Orphan Biovitrum ADR historical data, for real-time data please try another search

24.4 0.0 0.00%

09/04 - Closed. Currency in USD

Type: Equity

Market: United States

Volume: 0
Bid/Ask: 0.0 / 0.0
Day's Range: 24.4 - 24.4

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Swedish Orphan Biovitrum AB ADR Company Profile

Get an in-depth profile of Swedish Orphan Biovitrum AB ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

1806

Equity Type

ADR

Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. The company operates through three segments: Haematology, Immunology, and Specialty Care. It offers Alprolix for haemophilia B; ALTUVOCT for the treatment and prophylaxis of bleeding in patients with haemophilia A; Aspaveli/Empaveli for treating adult patients with paroxysmal nocturnal haemoglobinuria; Doptelet for the treatment of immune thrombocytopenia and thrombocytopenia; Elocta/Eloctate for the treatment and prophylaxis of bleeding in patients with haemophilia A; Gamifant for treating hemophagocytic lymphohistiocytosis; Kineret for the treatment of cryopyrin-associated periodic syndrome, rheumatoid arthritis, familial Mediterranean fever, deficiency of interleukin-1 receptor antagonist, and systemic juvenile idiopathic arthritis; Orfadin for hereditary tyrosinemia type 1 and alkaptonuria; Synagis for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus in infants and young children; VONJO, a kinase inhibitor indicated for the treatment of post-polycythemia vera or post-essential thrombocythemia myelofibrosis; and Zynlonta for treating adult patients with relapsed or refractory diffuse large and high grade B-cell lymphoma. The company also provides other medicines, such as Akynzeo, Aloxi, Jyseleca, Kepivance, Tegsedi, and Waylivra, as well as develops drug substances for ReFacto AF/Xyntha for Pfizer. The company has collaboration agreements with Sanofi, Apellis Pharmaceuticals, Inc., ADC Therapeutics SA, and Cartesian Therapeutics, Inc. Swedish Orphan Biovitrum AB (publ) was incorporated in 1939 and is headquartered in Stockholm, Sweden.

Contact Information

Address Norra Stationsgatan 93A
Stockholm,
Sweden

Phone 46 86 97 20 00

Fax -

Web www.sobi.com

Top Executives

Name	Age	Since	Title
Annette V. Clancy	70	2014	Independent Director
Linda Larsson	51	2020	Deputy Employee Representative Director
Mats Lek	40	2023	Deputy Employee Representative Director
Asa Kjellstrom	61	2023	Deputy Employee Representative Director
Christophe Bourdon	54	2023	Independent Director
Katy Mazibuko	51	2019	Employee Representative Director
Staffan Schuberg	55	2020	Independent Director
Filippa Stenberg	39	2021	Director
Sara Carlsson	42	2023	Deputy Employee Representative Director
Zlatko Rihter	54	2024	Director
Stephen O'Rahilly	-	-	Member of Scientific Advisory Board
Anders Ullman	68	2023	Director
Stefan Del Prato	-	-	Member of Scientific Advisory Board
David D. Meek	61	2024	Chairman
Ralf Pettersson	-	-	Member of Scientific Advisory Board
Jonathan Robert Sanders Arch	-	-	Member of Scientific Advisory Board
Susanna Ronnback	38	2024	Deputy Employee Representative Director
Helena Saxon	55	2011	Director
Iris Loew-Friedrich	-	2025	Board Member

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

SWTUY Comments

Write your thoughts about Swedish Orphan Biovitrum AB ADR

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,339.18	+30.90	+0.58%
NSE All Share	145,813.86	+1017.49	+0.70%
US 30	44,195.3	+83.6	+0.19%
US 500	6,343.8	+44.6	+0.71%
FTSE 100	9,164.31	+21.58	+0.24%
DAX	23,904.53	+58.46	+0.25%
South Africa Top 40	92,725.09	+529.59	+0.57%

Brent Oil	66.65	-0.99	-1.46%
Crude Oil WTI	64.10	-1.06	-1.63%
Gold	3,433.70	-1.00	-0.03%
Silver	37.913	+0.090	+0.24%
Copper	4.4158	+0.0298	+0.68%
London Cocoa	5,531.00	-20.00	-0.36%
London Wheat	172.45	-0.15	-0.09%

Nigeria 10Y	15.967	+0.002	+0.01%
Nigeria 2Y	16.481	+0.002	+0.01%
U.K. 10Y	4.5370	+0.0170	+0.38%
Germany 10Y	2.6438	+0.0018	+0.07%
U.S. 10Y	4.219	+0.023	+0.55%
U.S. 5Y	3.766	+0.004	+0.11%
U.S. 2Y	3.701	-0.015	-0.40%

Fidelitybk	21.400	-0.100	-0.47%
Zenith Bank	74.40	-1.50	-1.98%
UBA	48.10	-0.80	-1.64%
First HoldCo	32.40	+0.40	+1.25%
Guaranty Trust Holding	99.40	+0.40	+0.40%
Sterling Bank	8.160	+0.740	+9.97%
Dangote Cement	577.00	0.00	0.00%

Recent Quotes

Name	Price	Chg.	Chg. %
SWTUY	24.4	0.0	0.00%
Allan Gray Money .	1.000	0.000	0.00%
Riyad Commodity T.	6.257	+0.001	+0.01%
HKD/JPY	18.7491	-0.0495	-0.26%

Market Movers

Name	Last	Chg. %	Vol.
Sterling Bank	8.160	+9.97%	183.77M
Zenith Bank	74.40	-1.98%	60.35M
Access Holdings	27.50	+0.55%	56.24M
UBA	48.10	-1.64%	35.09M
Guaranty Trust Holding	99.40	+0.40%	15.13M
MTN Nigeria	480.00	0.00%	3.82M
Dangote Cement	577.00	0.00%	2.72M

Name	Last	Chg. %	Vol.
SCOA Nigeria	5.500	+10.00%	225.11K
Learn Africa	6.270	+10.00%	1.87M
Meyer	18.15	+10.00%	1.08M
Nem	29.700	+10.00%	460.45K
Mutual Benefits Assurance	2.42	+10.00%	19.25M
Jaiz Bank	4.73	+10.00%	20.48M
Guinness Nigeria	128.75	+10.00%	191.23K

Name	Last	Chg. %	Vol.
UAC Of Nigeria	90.00	-10.00%	6.94M
UH REIT	57.60	-10.00%	250.19K
Nigerian Exchange	63.00	-10.00%	12.71M
Livingtrust Mortgage Bank	5.35	-9.93%	399.81K
Multverse	9.80	-9.68%	565.22K
Rtbriscoe	3.50	-9.09%	947.90K
Initiates	13.00	-7.14%	6.17M